Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Alan W. L. Cheung"'
Autor:
Carolyn A. Cohen, Nancy H. L. Leung, Prathanporn Kaewpreedee, Kelly W. K. Lee, Janice Zhirong Jia, Alan W. L. Cheung, Samuel M. S. Cheng, Masashi Mori, Dennis K. M. Ip, Leo L. M. Poon, J. S. Malik Peiris, Benjamin J. Cowling, Sophie A. Valkenburg
Publikováno v:
Nature Communications, Vol 15, Iss 1, Pp 1-15 (2024)
Abstract Whole virion inactivated vaccine CoronaVac (C) and Spike (S) mRNA BNT162b2 (B) vaccines differ greatly in their ability to elicit neutralizing antibodies but have somewhat comparable effectiveness in protecting from severe COVID-19. We condu
Externí odkaz:
https://doaj.org/article/43c352f9d77447a8b416c96995ea3831
Autor:
Nancy H. L. Leung, Samuel M. S. Cheng, Carolyn A. Cohen, Mario Martín-Sánchez, Niki Y. M. Au, Leo L. H. Luk, Leo C. H. Tsang, Kelvin K. H. Kwan, Sara Chaothai, Lison W. C. Fung, Alan W. L. Cheung, Karl C. K. Chan, John K. C. Li, Yvonne Y. Ng, Prathanporn Kaewpreedee, Janice Z. Jia, Dennis K. M. Ip, Leo L. M. Poon, Gabriel M. Leung, J. S. Malik Peiris, Sophie A. Valkenburg, Benjamin J. Cowling
BackgroundThere are few trials comparing homologous and heterologous third doses of COVID-19 vaccination with inactivated vaccines and mRNA vaccines.MethodsWe conducted an open-label randomized trial in adults >=18 years of age who received two doses
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0cb3eaba37341c85d2e8e0ba7b3b4fe4
https://doi.org/10.1101/2022.08.25.22279158
https://doi.org/10.1101/2022.08.25.22279158
